Evidence map›Paper›PMID 35851618›Full record

ArticleProstate cancer and prostatic diseases2023

Single-port transvesical versus open simple prostatectomy: a perioperative comparative study.

Mahmoud Abou Zeinab, Aaron Kaviani, Ethan Ferguson, Alp T Beksac, Zeyad Schwen, Bradley Gill, Petar Bajic, James Ulchaker, Mohamed Eltemamy, Jihad Kaouk

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Editorial: new horizons in robotic platforms.Prostate cancer and prostatic diseases · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahmoud Abou ZeinabGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0001-8855-0004
Aaron KavianiGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Ethan FergusonGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Alp T BeksacGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Zeyad SchwenGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Bradley GillGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Petar BajicGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
James UlchakerGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Mohamed EltemamyGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Jihad KaoukGlickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. kaoukj@ccf.org.ORCID 0000-0002-7127-6069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the initial perioperative outcomes of single-port transvesical simple prostatectomy (SP RASP) patients to those of open simple prostatectomy (OSP). PATIENTS AND

methodsPerioperative data from 42 consecutive patients with BPH who underwent SP RASP were prospectively reviewed. Similarly, data from forty-three consecutive patients who underwent the standard OSP, were retrospectively collected. Through direct suprapubic bladder access, prostatic enucleation was performed using the prostatic capsule as a landmark. Then a complete vesicourethral mucosal advancement flap was accomplished. OSP was performed according to the standard approach. Demographics, Intra- and perioperative data were analyzed and assessed with a descriptive analysis. RESULTS AND LIMITATIONS: Baseline characteristics were comparable between the two groups, except for the preoperative median post-void residual volume, which was higher in the OSP group (p = 0.004). The SP RASP group had less intraoperative estimated blood loss (p < 0.001), no need for continuous bladder irrigation (p < 0.001), and less in-hospital opioid use (p < 0.001). Patients in the SP RASP group were discharged on postoperative day zero, compared to a median of 2 days for OSP (p < 0.001). The median Foley catheter duration was 7 days for SP RASP, compared to a median of 10 days for OSP (p < 0.001). SP RASP group had fewer postoperative complications, however, this did not reach statistical significance.

conclusionSP RASP is an alternative approach in treating surgical BPH. It may offer patients less morbidity in comparison to OSP.

Indexed as

Prostatic HyperplasiaProstatic NeoplasmsRobotic Surgical ProceduresBlood Loss, SurgicalHumansLength of StayMaleProstatectomyRetrospective StudiesTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.